United Pharm (033270) - Total Liabilities

Latest as of March 2026: ₩103.96 Billion KRW ≈ $70.45 Million USD

Based on the latest financial reports, United Pharm (033270) has total liabilities worth ₩103.96 Billion KRW (≈ $70.45 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore long-term investment intensity of United Pharm to see how much of total assets are deployed in long-term investments.

United Pharm - Total Liabilities Trend (2011–2025)

This chart illustrates how United Pharm's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see United Pharm balance sheet assets.

United Pharm Competitors by Total Liabilities

The table below lists competitors of United Pharm ranked by their total liabilities.

Company	Country	Total Liabilities
Renaissance Global Limited NSE:RGL	India	Rs8.69 Billion
Shangri-La Hotel Public Company Limited BK:SHANG	Thailand	฿528.09 Million
BAPCOR LTD. F:0BS	Germany	€971.27 Million
Crown Reserve Acquisition Corp. I Class A Ordinary Shares NASDAQ:CRAC	USA	$2.22 Million
Jai Corp Limited NSE:JAICORPLTD	India	Rs-15.10 Billion
Galata Acquisition Corp. II Class A Ordinary Shares NASDAQ:LATA	USA	$6.12 Million
AMA Group Limited F:KC7	Germany	€652.96 Million
Shangri La Hotels Malaysia Bhd KLSE:5517	Malaysia	RM353.21 Million

Liability Composition Analysis (2011–2025)

This chart breaks down United Pharm's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See how leveraged is United Pharm's balance sheet to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.36	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.23	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.18	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how United Pharm's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for United Pharm (2011–2025)

The table below shows the annual total liabilities of United Pharm from 2011 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩64.86 Billion ≈ $43.96 Million	-4.22%
2024-12-31	₩67.72 Billion ≈ $45.89 Million	-24.90%
2023-12-31	₩90.18 Billion ≈ $61.11 Million	+12.68%
2022-12-31	₩80.03 Billion ≈ $54.24 Million	+0.90%
2021-12-31	₩79.32 Billion ≈ $53.76 Million	+3.63%
2020-12-31	₩76.54 Billion ≈ $51.87 Million	+0.52%
2019-12-31	₩76.14 Billion ≈ $51.60 Million	+3.64%
2018-12-31	₩73.47 Billion ≈ $49.79 Million	+14.59%
2017-12-31	₩64.11 Billion ≈ $43.45 Million	+12.81%
2016-12-31	₩56.83 Billion ≈ $38.52 Million	+2.84%
2014-12-31	₩55.27 Billion ≈ $37.45 Million	+6.07%
2013-12-31	₩52.10 Billion ≈ $35.31 Million	-3.69%
2012-12-31	₩54.10 Billion ≈ $36.66 Million	-5.16%
2011-12-31	₩57.04 Billion ≈ $38.66 Million	--

About United Pharm

KO:033270 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$175.87 Million

₩259.52 Billion KRW

Market Cap Rank

#17127 Global

#673 in Korea

Share Price

₩17970.00

Change (1 day)

-1.26%

52-Week Range

₩16600.00 - ₩21400.00

All Time High

₩95918.11